Health Status of Children Born After Assisted Reproductive Technologies

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

January 19, 2024

Study Completion Date

January 22, 2024

Conditions
Children Born After Assisted Reproductive TechnologiesHealth StatusChild Development
Interventions
DIAGNOSTIC_TEST

hemogram examination

It will be studied hemogram examination, immunity indicators (cellular components CD3, CD4, CD8, CD16, CD20, CD25, CD95, CD3 HLA DR+, CD# HLA-DR; humoral components - IgM, IgA, IgE, IgG) and laboratory investigations in endocrine system (TSH, free T3 and T4 levels, insulin, insulin-like growth factor-1 (IGF-1), somatotropic hormone (STH); glucose, potassium, sodium) in 120 children born after ART. Researchers will compare 132 children conceived spontaneously to see if ART can influent on the health status in future.

Trial Locations (1)

050044

Scientific Center of Pediatrics and Pediatric Surgery, Almaty

All Listed Sponsors
collaborator

Vyacheslav Notanovich Lokshin

UNKNOWN

collaborator

Nurgalieva Zhanar Zhenisovna

UNKNOWN

collaborator

Manzhuova Lyazzat Nurbapayevna

UNKNOWN

collaborator

Abshekenova Aigerim Temirkhanovna

UNKNOWN

collaborator

Valeria Nekhorosheva

UNKNOWN

collaborator

Kusainova Farida Azimovna

UNKNOWN

lead

"Kazakhstan's Medical University KSPH"

OTHER

NCT06094998 - Health Status of Children Born After Assisted Reproductive Technologies | Biotech Hunter | Biotech Hunter